Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 5 of 5

“There was a discussion about these strange molecules called T bodies and we all thought it was a little bit hare-brained and I remember thinking… it’s going to be a real longshot,” says Robert Hershberg, chief scientific officer at Celgene

Robert Hershberg, chief scientific officer at Celgene, says that, after many years, CAR-T cell therapy might be just around the corner

Source  Courtesy of Robert Hershberg